subscribeSubscribe
GSK plays defense on call to pull popular children`s asthma med

GSK plays defense on call to pull popular children`s asthma med
FIERCE PHARMA
04 May 2024
Share Share
GSK launches once daily, single inhaler-triple therapy for COPD patients

GSK launches once daily, single inhaler-triple therapy for COPD patients
ECONOMICTIMES
26 Apr 2022
Share Share
CHMP opinions: EMA refuses asthma label expansion for GSK’s COPD Ellipta

CHMP opinions: EMA refuses asthma label expansion for GSK’s COPD Ellipta
Allie Nawrat PHARMACEUTICAL-TECHNOLOGY
01 Mar 2021
Share Share
FDA Approvals Roundup: Detectnet, Nityr, Trelegy Ellipta

FDA Approvals Roundup: Detectnet, Nityr, Trelegy Ellipta
R. Matthews RAPS
16 Sep 2020
Share Share
GSK books 19% sales growth for first quarter

GSK books 19% sales growth for first quarter
Selina McKee PHARMATIMES
29 Apr 2020
Share Share
GSK filing accepted by European Medicines Agency for Trelegy Ellipta

GSK filing accepted by European Medicines Agency for Trelegy Ellipta
PRESS RELEASE
27 Feb 2020
Share Share
GSK Submits Filing to FDA for Trelegy Ellipta Use in Patients With Asthma

GSK Submits Filing to FDA for Trelegy Ellipta Use in Patients With Asthma
BUSINESSWIRE
03 Oct 2019
Share Share
AstraZeneca respiratory business gets boost from 3-drug inhaler results

AstraZeneca respiratory business gets boost from 3-drug inhaler results
Ludwig Burger REUTERS
29 Aug 2019
Share Share
AstraZeneca’s COPD triplet Breztri nabs first nod from Japan

AstraZeneca’s COPD triplet Breztri nabs first nod from Japan
Angus Liu FIERCE PHARMA
20 Jun 2019
Share Share
FDA draft lays out submission paths for combo products

FDA draft lays out submission paths for combo products
David Lim MEDTECH DRIVE
07 Feb 2019
Share Share